Related Experiment Video

Updated: Aug 15, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders

R Rosenfeld, D B Allen, M H MacGillivray

    The American Journal of Managed Care
    |February 24, 2001
    PubMed

    Insights

    This article addresses clinical and economic challenges in diagnosing and managing pediatric growth disorders, focusing on growth hormone (GH) therapy. It covers evaluation, treatment indications, dosing, outcomes, and payer perspectives for various pediatric conditions.

    Area of Science:

    • Pediatric Endocrinology
    • Growth Hormone Therapy
    • Clinical Economics

    Background:

    • Growth disorders in children present complex clinical and economic challenges.
    • Growth hormone (GH) therapy is a key treatment modality, necessitating careful consideration of its application.

    Purpose of the Study:

    • To provide a comprehensive overview of the diagnosis and management of pediatric growth disorders.
    • To examine the clinical, economic, and payer perspectives on growth hormone therapy in children.

    Main Methods:

    • Review of current literature and expert opinions on growth hormone therapy.
    • Discussion of diagnostic criteria, therapeutic indications, dosing strategies, and outcomes.
    • Analysis of payer policies and managed care perspectives on GH treatment coverage.

    Main Results:

    • The article synthesizes expert insights on evaluating short stature and diagnosing GH deficiency.
    • It details anabolic and metabolic GH treatment indications, optimal dosing, and follow-up protocols.
    • Payer perspectives highlight policy development for guiding GH treatment decisions and coverage.

    Conclusions:

    • Effective management of pediatric growth disorders requires a multidisciplinary approach integrating clinical expertise and economic considerations.
    • Optimizing growth hormone therapy necessitates evidence-based guidelines for diagnosis, treatment, and coverage.
    • Addressing the economic aspects of GH therapy is crucial for ensuring patient access and appropriate utilization.

    More Related Videos

    A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies06:53

    A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies

    Published on: July 4, 2017

    Tricolor Transgenic Murine Model for Studying Growth Plate Injury07:58

    Tricolor Transgenic Murine Model for Studying Growth Plate Injury

    Published on: September 6, 2024

    Related Concept Videos

    Nature and Nurture01:10

    Nature and Nurture

    Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
    Hedgehog Signaling Pathway02:33

    Hedgehog Signaling Pathway

    The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...